Search - tctmd.com

Displaying 61 - 74 of 74

Sort: Relevancy | Date

Presentation THT Abstracts 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 11, 2025

Presentation THT 2025

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Presenter: Richa Gupta

February 11, 2025

Presentation THT 2025

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Presenter: Patrick McCann

February 11, 2025

Presentation THT 2025

Drug and Device Therapies to Target the Neurohormonal Cascade

Presenter: Rajeev Mohan

February 11, 2025

News Conference News ISC 2025

Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels

Todd Neale

February 06, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Video

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

March 5, 2025

Partner Content

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

March 5, 2025

CME

Advertisement

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Drug and Device Therapies to Target the Neurohormonal Cascade

Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients

The Role of Atrial Shunts in the Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content